China National Pharmaceutical Holdings (01099.HK) was increased by JPMorgan Chase with an additional 749,800 shares.

NightAirdropper · 2026-03-15T17:38:06+00:00

Gelonghui March 12 | According to the latest equity disclosure information from the Hong Kong Stock Exchange, on March 9, 2026, China National Pharmaceutical Holdings (01099.HK received an increase in its holdings by JPMorgan Chase & Co. at an average price of HK$20.4501 per share, with 749,800 shares purchased, involving approximately HK$15.3332 million.After the increase, JPMorgan Chase & Co.'s total holdings amount to 67,675,600 shares, and its holding ratio has risen from 4.98% to 5.04%.

NightAirdropper

2026-03-15 17:38:06

Gelonghui March 12 — According to the latest disclosure of interests from the Hong Kong Stock Exchange, on March 9, 2026, China National Pharmaceutical Group (01099.HK) was increased by JPMorgan Chase & Co. with an additional 749,800 shares at an average price of HKD 20.4501 per share, involving approximately HKD 15.33 million.

After the increase, JPMorgan Chase & Co.'s total holdings amount to 67.6756 million shares, with the holding ratio rising from 4.98% to 5.04%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes